- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-122554) pertaining to the 2004 Equity Compensation Plan of Meridian Bioscience, Inc.; |
(2) | Registration Statement (Form S-8 No. 333-155703) pertaining to the 2004 Equity Compensation Plan (as Amended and Restated Through January 22, 2008) of Meridian Bioscience, Inc.; |
(3) | Registration Statement (Form S-8 No. 333-179440) pertaining to the 2012 Stock Incentive Plan of Meridian Bioscience, Inc.; |
(4) | Registration Statement (Form S-8 No. 333-252538) pertaining to the 2021 Omnibus Award Plan of Meridian Bioscience Inc.; and |
(5) | Registration Statement (Form S-3 File No. 333-250878) of Meridian Bioscience, Inc.; |
of our reports dated November 23, 2021, with respect to the consolidated financial statements and schedule of Meridian Bioscience, Inc. and the effectiveness of internal control over financial reporting of Meridian Bioscience, Inc. included in this Annual Report (Form 10-K) of Meridian Bioscience, Inc. for the year ended September 30, 2021.
/s/ Ernst & Young LLP
Cincinnati, Ohio
November 23, 2021